Question 1

How many shares of CTXR does BlackRock, Inc. own?

Accepted Answer

As of 2026-Q2, BlackRock, Inc. holds 69,850 shares of CTXR (CITIUS PHARMACEUTICALS INC).

Question 2

What is BlackRock, Inc.'s CTXR position worth?

Accepted Answer

As of 2026-Q2, BlackRock, Inc.'s CTXR position is worth $42,224.

Question 3

Is BlackRock, Inc. buying or selling CTXR?

Accepted Answer

In 2026-Q2, BlackRock, Inc. decreased their CTXR position (0.0% change in shares).

Question 4

When did BlackRock, Inc. first buy CTXR?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in CTXR in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	69,850	0.0%	$42,224	0.0%	$0.61	0
2026-Q1	Unchanged	69,851	0.0%	$62,866	0.0%	$0.74	0
2025-Q4	Unchanged	69,851	0.0%	$54,274	0.0%	$0.78	0
2025-Q3	Unchanged	69,851	0.0%	$86,615	0.0%	$1.18	0
2025-Q2	Decreased	69,851	-3.3%	$111,063	0.0%	$1.53	0
2025-Q1	Unchanged	72,227	0.0%	$107,618	0.0%	$1.55	0
2024-Q4	New	72,227	-	$288,908	0.0%	$3.91	36

CTXR7 quarters

CTXR
7 quarters